Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21482186 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Condition: Diffuse Large B Cell Lymphoma
Interventions: Drug: Rituximab;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone
2 Unknown  Mini-CHOP and Rituximab in Patients Aged Over 80 Years
Condition: Diffuse Large B-cell Lymphoma
Intervention: Drug: RminiCHOP

Indicates status has not been verified in more than two years